These scores were not developed to substitute for ADAMTS13 activity testing, which is vital in the confirmation and follow-up of TTP, but to facilitate the clinical diagnosis of this life-threatening disease. This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.